NEONATAL SCROTAL WALL NECROTIZING FASCITIS (FOURNIER GANGRENE SCROTUM) IN A ONE MONTH OLD NEONATAL: A RARE CASE REPORT
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: In this report, we present our case of a one-month-old neonatal with Fournier gangrene who was referred to our hospital. Case(s) Presentation: A one-month-old patient came from a referral hospital with chief complaint had a diaper rash since 6 days before hospital admission, fever existed, and patient’s scrotal became swollen and appear white spot. The patient was referred to Ulin General Hospital Banjarmasin for a necrotomy debridement. Discussion: We recommend more than one antibiotic to cover it, including one specifically targeted toward it. Both Enterococcus and S. aureus have been implicated as the causative organisms of Fournier gangrene in previous reports. Conclusion: Fournier gangrene in neonatal is a rare case and potentially life-threatening disease, it is a progressive gangrenous of the genitalia, perineum and perianal regions. Keyword: Fournier gangrene, scrotal, neonatal
##plugins.themes.bootstrap3.article.details##
Fournier gangrene, scrotal, neonatal
Woodside JR: Necrotizing fasciitis after neonatal circumcision. Am J Dis Child. 1980; 134: 301-302.
Gangopadhyay AN, Pandey A, Upadhyay VD, Sharma SP, Gupta DK, Kumar V: Neonatal necrotising fasciitis - Varanasi experience. Int Wound J. 2008; 5: 108-112.
Dey S, Bhutia KL, Baruah AK, Kharga B, Mohanta PK, Singh VK: Neonatal Fournier’s gangrene. Arch Iran Med. 2010; 13: 360-362.
Abubakar AM, Bello MA, Tahir BM, Chinda JY. Fournier's gangrene in children: A report of 2 cases. J Surg Techn Case Rep. 2009; 1(1): 34–6.
Ameh EA, Dauda MM, Sabiu L, et al. Fournier's gangrene in neonates and infants. Eur J Pediatr Surg. 2004; 14(6): 418–21.
Ruiz-Tovar J, Córdoba L, Devesa JM. Prognostic factors in Fournier gangrene. Asian J Surg. 2012; 35(1): 37–41.
Wróblewska M, Kuzaka B, Borkowski T, Kuzaka P, Kawecki D, Radziszewski P. Fournier’s Gangrene – Current Concepts. Pol J Microbiol. 2014; 63(3): 267–673.
Canbaz H, Caglikulekci M, Altun U, Dirlik M, Turkmenoglu O, Taşdelen B, et al. Fournier’s gangrene:analysis of risk factors affecting the prognosis and cost of therapy in 18 cases. Ulus Travma Acil Cerrahi Derg. 2010; 16(1): 71–76.
Kabay S, Yucel M, Yaylak F, et al. The clinical features of Fournier’s gangrene and the predictivity of the Fournier’s Gangrene Severity Index on the outcomes. Int Urol Nephrol. 2008; 40(4): 997–1004.
Eke N. Fournier's gangrene : A review of 1726 cases. Br J Surg. 2000; 87: 718-728.
Garcés C, Gómez C, Florez ID, Muñoz JD. [An unusual presentation of Fournier's gangrene. Is there a relationship with NSAID use? Pediatric case report]. Rev Chilena Infectol. 2010; 27(4): 341–4.
Thwaini A, Khan A, Malik A, Cherian J, Barua J, Shergill I et al. Fournier’s gangrene and its emergency management. Postgrad Med J. 2006; 82: 516–9.
Elliott D, Kufera JA, Myers RA. The microbiology of necrotizing soft tissue infections. Am J Surg. 2000; 179: 361–6.
Pawlowski W, Wronski M, Krasnodebski IW. Fournier’s gangrene. Pol Merkur Lekarski. 2004; 17: 85–7
Ekingen G, Isken T, Agir H, Oncel S, Günlemez A. Fournier’s gangrene in childhood: a report of 3 infant patients. J Pediatr Surg. 2008; 43: E39–42.